Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SATURN: Solifenacin + Tamsulosin for LUTS/BPH
NCT00510406Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Jan 2007
- Primary completion
- Sep 2007
- Modality
- Orthosteric Ligands
- Countries
- 16
01
Overview
A Phase 2 trial of solifenacin in lower urinary tract symptoms (LUTS), benign prostatic hyperplasia (BPH), sponsored by Astellas Pharma. Started Jan 2007; status: completed.
02
Drugs
solifenacin
03
Conditions
lower urinary tract symptoms (LUTS)benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00510406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00510406.